Amgen

In the last 7 days

Amgen Renews Push for Colorado Payment Cap Halt At Appeals Court Bloomberg Law16:49 16-Jun-25

Amgen And Football Legend Barry Sanders Highlight Dangers Of Bad Cholesterol In New Documentary Amgen (Press Release)14:01 13-Jun-25

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider Zacks23:52 12-Jun-25

In the last month

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks15:05 9-Jun-25

Amgen launches Korean phase 3 trial for heart drug targeting high lipoprotein Korea Biomedical Review06:45 9-Jun-25

Amgen To Present At Goldman Sachs 46TH Annual Global Healthcare Conference Amgen (Press Release)21:10 5-Jun-25

Samsung Bioepis Secures Marketing Approval in Korea for its Biosimilar to Amgen’s Bone Cancer Drug Xgeva JD Supra17:42 4-Jun-25

Genomics pioneer fired from firm he founded: ‘It was not easy to domesticate me’ Nature.com11:03 4-Jun-25

Amgen's Imdelltra Cuts Lung Cancer Death Risk by 40% in Phase III Zacks15:52 3-Jun-25

ASCO25: Amgen’s Nplate proves effective in GI cancer-linked thrombocytopaenia Pharmaceutical Technology08:54 3-Jun-25

Imdelltra® Significantly Reduced Risk Of Death By 40% In Small Cell Lung Cancer Patients PR Newswire (Press Release)13:10 2-Jun-25

3 No-Brainer Healthcare Stocks to Buy in June The Motley Fool12:10 2-Jun-25

Samsung Bioepis gets Korean nod for biosimilar of Amgen’s bone drug Xgeva Korea Biomedical Review03:39 2-Jun-25

Amgen To Present At Jefferies Global Healthcare Conference Amgen (Press Release)21:03 30-May-25

July 11th Options Now Available For Amgen (AMGN) Nasdaq16:07 29-May-25

Is Amgen Stock a Buy? The Motley Fool09:47 29-May-25

Alexion awarded injunction against Amgen in SOLIRIS patent action; Court considers anticipation by incorporation by… JD Supra19:37 27-May-25

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks15:07 27-May-25

Better Weight Loss Stock: Amgen or Viking Therapeutics? The Motley Fool16:05 22-May-25

HyClone Seeks to Quash Amgen’s Subpoena Issued in Amgen/Accord Denosumab BPCIA Litigation JD Supra20:05 21-May-25

Regeneron Awarded $407 Million in Amgen Antitrust Suit JD Supra18:16 20-May-25

Amgen vs Bristol Myers: Which Biotech Giant Has Better Prospects? Zacks19:40 19-May-25

Regeneron Win Underscores Importance of Simple Market Definition Bloomberg Law18:45 19-May-25

view more headlines

16 Jun 16:49

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.